Aaron C. Logan
0000-0002-1179-5879
Publication & Citation Trends
Most Cited Works
Publications
381 total
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia PDF
Cited by 173
OpenAlex
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study PDF
Cited by 751
OpenAlex
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study PDF
Cited by 311
OpenAlex
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology PDF
Cited by 238
OpenAlex
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results PDF
Cited by 195
OpenAlex
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia PDF
Cited by 424
OpenAlex
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts PDF
Cited by 132
OpenAlex
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy PDF
Cited by 491
OpenAlex
Research Topics
Acute Lymphoblastic Leukemia research
(98)
CAR-T cell therapy research
(80)
Acute Myeloid Leukemia Research
(62)
Chronic Myeloid Leukemia Treatments
(51)
Chronic Lymphocytic Leukemia Research
(48)
Frequent Co-Authors
Affiliations
Otsuka (Japan)
University of Southern California
International Union for Conservation of Nature (Bangladesh)
Novartis (Switzerland)
National Marrow Donor Program